As immunogenicity is an important inherent feature of tumor cells, the constructed APM signature score and risk score were found to be more associated with higher tumor grade, CL and ME subtypes, IDH wildtype, 1p19q non-codeletion, unmethylated MGMT promoter as expected, all of which indicated more malignancy of gliomas. This evidence concerns the gene IDH1 and neoplasm.